Stephen Schuster, MD
Enriched profileRobert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research; Director, Lymphoma Program; Director, Lymphoma Translational Research, Abramson Cancer Center · Perelman School of Medicine at the University of Pennsylvania
Stephen Schuster is Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research; Director, Lymphoma Program; Director, Lymphoma Translational Research, Abramson Cancer Center at Perelman School of Medicine at the University of Pennsylvania. OpenAlex indexes 804 publications with 33,743 citations (h-index 77); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Stephen Schuster, MD, is Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research at Perelman School of Medicine at the University of Pennsylvania / Hospital of the University of Pennsylvania, Department of Medicine, Division of Hematology-Oncology; Abramson Cancer Center. The public record shows 804 publications with 33,743 citations (h-index 77), centered on Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 25 companies, 3 NIH-funded awards (1986–2024).
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Lymphoma Diagnosis and Treatment
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 25 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 290.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma
Sponsor: University of Pennsylvania
- SynKIR-310 for Relapsed/Refractory B-NHL
Sponsor: Verismo Therapeutics
- CAR-T Followed by Bispecific Antibodies
Sponsor: Abramson Cancer Center at Penn Medicine
Industry payments
Updated 27 Aug 2026
25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
- ABBVIE INC.Program year20254 payments
- Chugai Pharmaceutical Co., Ltd.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
45.8%Kinase inhibitor45.8%Jaypirca58%Calquence42%Part D<11 patientsMetabolism & gastrointestinal
29.2%Corticosteroid29.2%Prednisone100%Part D<11 patientsAnti-infectives
25%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor25%Valacyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 1986–2024 per NIH RePORTER. The latest:
- Models and methods for automatically measuring disease body-wide and staging disease via FDG-PET/CT in Lymphoma
University of Pennsylvania
FY2024$545,026R01CA255748 - Models and methods for automatically measuring disease body-wide and staging disease via FDG-PET/CT in Lymphoma
University of Pennsylvania
FY2023$547,725R01CA255748 - Models and methods for automatically measuring disease body-wide and staging disease via FDG-PET/CT in Lymphoma
University of Pennsylvania
FY2022$599,500R01CA255748
Congress activity
Updated 27 Aug 2026
224 congress contributions (2006–2025) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01
- 02PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma3,550 citations2014
- 03Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas1,857 citations2017
- 04Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia1,620 citations2014
- 05PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma1,062 citations2014
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephen-schuster-md-604259e3
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Stephen-Schuster-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/stephen-schuster-93a29114b
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
investor.cariboubio.com/news-releases/news-release-details/caribou-biosciences-announces-appointment-stephen-j-schuster-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →investor.cariboubio.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Lymphoma Translational Research, Abramson Cancer Center of the University of Pennsylvania
2008verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- Member
American Society of Hematology; American Society of Clinical Oncology; American Association for Cancer Research; Eastern Cooperative Oncology Group (ECOG)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
- Member
Scientific Advisory Board, Biovest International Inc.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗ - Member
Scientific Advisory Board, Caribou Biosciences, Inc.
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →investor.cariboubio.com ↗
Media & interviews
press, podcasts and appearances- ImmunoLogic
Episode 1: "Chemo-Free Lymphoma? Seriously?", video podcast interview with Stephen J. Schuster, MD, hosted by Joseph Fraietta, PhD (CGTLive)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cgtlive.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cgtlive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Francis Marchlinski, MD
Perelman School of Medicine at the University of Pennsylvania
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
Jay Giri, MD
Perelman School of Medicine at the University of Pennsylvania
Michael Thase, MD
Perelman School of Medicine at the University of Pennsylvania